Oxidative stress triggers metabolic reprogramming in immune cells, causing them to secrete inflammatory factors that promote squamous cell carcinoma invasion. Blocking the IL-1β signaling pathway suppresses this invasion more effectively than targeting glutamine metabolism alone, suggesting a direct therapeutic intervention point.
Key Points
- Senescent macrophages accumulate with oxidative stress and correlate with tumor malignancy
- Glutamine metabolism drives IL-1β secretion in aging immune cells
- IL-1β blockade suppresses tumor invasion more effectively than glutamine inhibition
Longevity Analysis
This research demonstrates how oxidative stress reshapes the tumor microenvironment by altering how immune cells process nutrients and communicate. The metabolic reprogramming of aging macrophages—shifting their glutamine utilization to produce inflammatory signaling molecules—represents a mechanistic link between cellular senescence, chronic inflammation, and cancer progression. For individuals managing cancer risk or post-treatment surveillance, this suggests that strategies reducing oxidative stress may prevent the immune system from inadvertently supporting tumor growth, while selective inhibition of IL-1β signaling could interrupt this pathway without the broader metabolic disruption that glutamine inhibition would cause.
Original published by Wiley Aging Cell, by Shimeng Wang, Jingtian Mu, Wei Zhao, Can Hu, Xueke Shi, Hongmei Zhou, Junjiang Liu, Fanglong Wu .